AI Analysis AI Analysis of NVAX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NVAX to Watchlist?
Some Reasons Why To Add NVAX:
  • High gross margin of 84.6%
  • Strong return on equity of 89.7%
  • Bullish trend confirmed on both short and long timeframes
PDF

Red day on Tuesday for Novavax
(Updated on Jun 23, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jun 22, 2026

No changes to the price of Novavax stock on the last trading day (Tuesday, 23rd Jun 2026). During the last trading day the stock fluctuated 8.85% from a day low at $8.81 to a day high of $9.59. The price has fallen in 5 of the last 10 days but is still up by 4.41% over the past 2 weeks.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $8.75 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 14.63% during the next 3 months and, with a 90% probability hold a price between $10.03 and $13.20 at the end of this 3-month period.

NVAX Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 5.14%. Further rise is indicated until a new top pivot has been found. The volume rose on the last day while price remained unchanged. This may be an early warning and the stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Novavax stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.13 and $9.40. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Novavax stock

Novavax finds support from accumulated volume at $8.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.780 between high and low, or 8.85%. For the last week, the stock has had daily average volatility of 7.41%.

Our recommended stop-loss: $8.54 (-5.11%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (NVAX) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Novavax Inc to open at $9.13, and during the day (based on 14 day Average True Range), to move between $8.68 and $9.32, which gives a possible trading interval of +/-$0.643 (+/-7.40%) up or down from last closing price. If Novavax Inc takes out the full calculated possible swing range there will be an estimated 7.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.23 (2.56%) than the support at $8.67 (3.67%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Novavax Inc stock A Buy?

Novavax holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.219 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $9.13 ( 1.48%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NVAX Performance

Trading levels for NVAX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.91 10.15%
R2 9.62 6.84%
R1 9.43 4.79%
Price 9.00
S1 8.84 -1.83%
S2 8.65 -3.87%
S3 8.35 -7.19%

Accumulated Volume Support & Resistance Levels

Level Price
R3 9.50 5.56%
R2 9.36 4.00%
R1 9.23 2.56%
Price 9.00
S1 8.67 -3.67%
S2 8.62 -4.22%
S3 8.45 -6.11%

FAQ

What is the symbol for Novavax Stock and on which exchange is it traded?
The symbol for Novavax is NVAX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Novavax Stock?
Novavax holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Novavax Stock?
Novavax Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novavax Stock.

What's the current price of Novavax Stock?
As of the end of day on the Jun 23, 2026, the price of an Novavax (NVAX) share was $9.00.

What is the 52-week high and low for Novavax Stock?
The 52-week high for Novavax Stock is $11.97 and the 52-week low is $6.14.

What is the market capitalization of Novavax Stock?
As of the Jun 23, 2026, the market capitalization of Novavax is 1.48B.

When is the next earnings date for Novavax?
The upcoming earnings date for Novavax is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT NOVAVAX INC
Novavax
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
OSW
$24.00
17.08% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE